Provided By Globe Newswire
Last update: Aug 31, 2022
Company announcement – No. 37 / 2022
Total number of shares and voting rights in Zealand Pharma at August 31, 2022
Copenhagen, DK and Boston, MA, August 31, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.
Read more at globenewswire.com